 |
PDBsum entry 3dei
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase, apoptosis
|
PDB id
|
|
|
|
3dei
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase, apoptosis
|
 |
|
Title:
|
 |
Crystal structures of caspase-3 with bound isoquinoline-1,3,4-trione derivative inhibitors
|
|
Structure:
|
 |
Caspase-3. Chain: a, b, c, d. Synonym: casp-3, apopain, cysteine protease cpp32, yama protein, cpp- 32, srebp cleavage activity 1, sca-1, caspase-3 subunit p17, caspase- 3 subunit p12. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.215
|
R-free:
|
0.291
|
|
|
Authors:
|
 |
J.Wu,J.Du,J.Li,J.Ding
|
Key ref:
|
 |
J.Q.Du
et al.
(2008).
Isoquinoline-1,3,4-trione Derivatives Inactivate Caspase-3 by Generation of Reactive Oxygen Species.
J Biol Chem,
283,
30205-30215.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Jun-08
|
Release date:
|
02-Sep-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P42574
(CASP3_HUMAN) -
Caspase-3 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
277 a.a.
232 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
283:30205-30215
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Isoquinoline-1,3,4-trione Derivatives Inactivate Caspase-3 by Generation of Reactive Oxygen Species.
|
|
J.Q.Du,
J.Wu,
H.J.Zhang,
Y.H.Zhang,
B.Y.Qiu,
F.Wu,
Y.H.Chen,
J.Y.Li,
F.J.Nan,
J.P.Ding,
J.Li.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Caspase-3 is an attractive therapeutic target for treatment of diseases
involving disregulated apoptosis. We report here the mechanism of caspase-3
inactivation by isoquinoline-1,3,4-trione derivatives. Kinetic analysis
indicates the compounds can irreversibly inactivate caspase-3 in a
1,4-dithiothreitol (DTT)- and oxygen-dependent manner, implying that a redox
cycle might take place in the inactivation process. Reactive oxygen species
detection experiments using a chemical indicator, together with electron spin
resonance measurement, suggest that ROS can be generated by reaction of
isoquinoline-1,3,4-trione derivatives with DTT. Oxygen-free radical scavenger
catalase and superoxide dismutase eliciting the inactivation of caspase-3 by the
inhibitors confirm that ROS mediates the inactivation process. Crystal
structures of caspase-3 in complexes with isoquinoline-1,3,4-trione derivatives
show that the catalytic cysteine is oxidized to sulfonic acid (-SO(3)H) and
isoquinoline-1,3,4-trione derivatives are bound at the dimer interface of
caspase-3. Further mutagenesis study shows that the binding of the inhibitors
with caspase-3 appears to be nonspecific. Isoquinoline-1,3,4-trione
derivative-catalyzed caspase-3 inactivation could also be observed when DTT is
substituted with dihydrolipoic acid, which exists widely in cells and might play
an important role in the in vivo inactivation process in which the inhibitors
inactivate caspase-3 in cells and then prevent the cells from apoptosis. These
results provide valuable information for further development of small molecular
inhibitors against caspase-3 or other oxidation-sensitive proteins.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 6.
Crystal structures of caspase-3 in complexes with inhibitors.
A, a ribbon diagram shows the overall structure of caspase-3. B,
molecular surface maps represent the hydrophobic pocket with the
bound inhibitors. C, a stereo view shows the composition of the
hydrophobic pocket at the dimer interface and the oxidation of
the catalytic cysteine (Cys^163) to sulfonic acid. D, the four
inhibitors are superimposed at the binding site within bound
compounds I, II, III, and IV colored in magenta, green, cyan,
and yellow, respectively. E, a stereo view shows the catalytic
active site of molecule C. The 2F[o] - F[c] sa_omit_map (1σ
contour level) for the oxidized catalytic cysteine and the
residues nearby are shown with cyan meshes.
|
 |
Figure 7.
Proposed scheme for the catalytic inactivation of caspase-3
by isoquinoline-1,3,4-trione derivatives through redox cycling.
In the presence of DTT in vitro and possibly dihydrolipoic acid
in vivo, isoquinoline-1,3,4-trione derivatives rapidly undergo
reduction to the corresponding semiquinone anion radicals
(RQ^-). The reaction is reversible in the presence of
atmospheric oxygen by reduction oxygen to ROS. The farther
oxidation of DTT and dihydrolipoic acid intermediate also could
generate ROS (38, 39). The produced ROS catalyzes the step by
step oxidation of the active site cysteine of caspase-3 to the
sulfonic acid. The semiquinone anion radicals may also
contribute to the specific oxidation of the catalytic cysteine
via a intermediate (Caspase-SH/RQ^-). Caspase-SH, caspase-SOH,
caspase-SO[2]H, and caspase-SO[3]H represent the thiol,
sulfenic, sulfinic, and sulfonic acid states of the catalytic
cysteine.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the ASBMB:
J Biol Chem
(2008,
283,
30205-30215)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Huang,
H.Yu,
Z.Miao,
J.Zhou,
S.Wang,
H.K.Fun,
J.Xu,
and
Y.Zhang
(2011).
Facile synthesis of spiroisoquinolines based on photocycloaddition of isoquinoline-1,3,4-trione with oxazoles.
|
| |
Org Biomol Chem,
9,
3629-3631.
|
 |
|
|
|
|
 |
A.Jadhav,
R.S.Ferreira,
C.Klumpp,
B.T.Mott,
C.P.Austin,
J.Inglese,
C.J.Thomas,
D.J.Maloney,
B.K.Shoichet,
and
A.Simeonov
(2010).
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.
|
| |
J Med Chem,
53,
37-51.
|
 |
|
|
|
|
 |
C.Ottmann,
P.Hauske,
and
M.Kaiser
(2010).
Activation instead of inhibition: targeting proenzymes for small-molecule intervention.
|
| |
Chembiochem,
11,
637-639.
|
 |
|
|
|
|
 |
K.Hong,
A.H.Gao,
Q.Y.Xie,
H.Gao,
L.Zhuang,
H.P.Lin,
H.P.Yu,
J.Li,
X.S.Yao,
M.Goodfellow,
and
J.S.Ruan
(2009).
Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China.
|
| |
Mar Drugs,
7,
24-44.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |